Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss
Recruiting
Observational Study
Periodontal Diseases
Hyperuricemia
Oxidative Stress
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- Recep Tayyip Erdogan University Training and Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Periodontitis is a multifactorial disease characterized by chronic inflammation of the gum tissue and alveolar bone destruction, and is known to be associated with various systemic diseases. Hyperuricemia, on the other hand, is a metabolic condition characterized by increased serum uric acid levels and can affect inflammation, oxidative stress, and bone metabolism. In recent years, the relationshi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Being between 18 and 65 years of age
* Being systemically healthy or diagnosed with hyperuricemia
* Having at least 20 natural teeth
* Being periodontally healthy or diagnosed with periodontitis
Exclusion Criteria:
* Diabetes, cardiovascular disease, osteoporosis, chronic ki…
Contacts